BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Ethan Allen Interiors
ETD
$602M
| $45.7M | ﹤0.01% |
3,865,652
+46,583
| +1% | +$517K |
|
|
EBSB
2302
DELISTED
Meridian Bancorp, Inc.
EBSB
| $45.6M | ﹤0.01% |
3,929,171
+3,467
| +0.1% | +$38.5K |
|
|
BCEL
2303
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $45.6M | ﹤0.01% |
2,141,779
+278,190
| +15% | +$4.92M |
|
|
SWT
2304
DELISTED
Stanley Black & Decker, Inc.
SWT
| $45.5M | ﹤0.01% |
508,591
-37,069
| -7% | -$3.02M |
|
2305
Gildan
GIL
$10.8B
| $45.4M | ﹤0.01% |
2,931,993
+754,117
| +35% | +$11.1M |
|
2306
iShares MSCI Switzerland ETF
EWL
$2.23B
| $45.4M | ﹤0.01% |
1,165,602
-716,346
| -38% | -$26.9M |
|
2307
Antero Resources
AR
$11.6B
| $45.4M | ﹤0.01% |
17,878,046
+7,713,179
| +76% | +$20.2M |
|
2308
Ameresco
AMRC
$1.37B
| $45.2M | ﹤0.01% |
1,626,037
+7,619
| +0.5% | +$154K |
|
|
FLXN
2309
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $45.1M | ﹤0.01% |
3,432,052
+461,242
| +16% | +$4.78M |
|
|
NGM
2310
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $45.1M | ﹤0.01% |
2,285,474
+33,968
| +2% | +$649K |
|
2311
Arcturus Therapeutics
ARCT
$214M
| $45M | ﹤0.01% |
963,362
+887,938
| +1,177% | +$30.6M |
|
2312
Rogers Communications
RCI
$19.1B
| $44.9M | ﹤0.01% |
1,116,387
-1,079,158
| -49% | -$44.9M |
|
2313
Fomento Económico Mexicano
FMX
$40.3B
| $44.8M | ﹤0.01% |
723,035
-755,651
| -51% | -$48.1M |
|
2314
Tronox
TROX
$1.02B
| $44.7M | ﹤0.01% |
6,189,319
-176,201
| -3% | -$1.16M |
|
|
GLDD
2315
DELISTED
Great Lakes Dredge & Dock
GLDD
| $44.6M | ﹤0.01% |
4,818,758
+142,119
| +3% | +$1.24M |
|
|
TSC
2316
DELISTED
TriState Capital Holdings, Inc.
TSC
| $44.6M | ﹤0.01% |
2,838,724
-881,112
| -24% | -$12M |
|
2317
Inseego
INSG
$84.9M
| $44.5M | ﹤0.01% |
384,026
+45,826
| +14% | +$4.85M |
|
2318
Univest Financial
UVSP
$1.18B
| $44.5M | ﹤0.01% |
2,759,533
+84,620
| +3% | +$1.36M |
|
|
HAYN
2319
DELISTED
Haynes International, Inc.
HAYN
| $44.5M | ﹤0.01% |
1,903,965
-35,862
| -2% | -$797K |
|
|
CPE
2320
DELISTED
Callon Petroleum Company
CPE
| $44.3M | ﹤0.01% |
3,854,231
-2,080,003
| -35% | -$18.4M |
|
|
XLNX
2321
CALL
DELISTED
Xilinx Inc
XLNX
| $44.1M | ﹤0.01% |
448,500
+328,500
| +274% | +$29.1M |
|
2322
1-800-Flowers.com
FLWS
$259M
| $44M | ﹤0.01% |
2,197,455
-352,934
| -14% | -$6.96M |
|
2323
El Pollo Loco
LOCO
$452M
| $43.9M | ﹤0.01% |
2,977,489
-135,307
| -4% | -$1.74M |
|
2324
Zentalis Pharmaceuticals
ZNTL
$295M
| $43.8M | ﹤0.01% |
+912,549
| New | +$35M |
|
|
TECX
2325
Tectonic Therapeutic
TECX
$623M
| $43.8M | ﹤0.01% |
208,926
+45,797
| +28% | +$9.44M |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.